Cyclic peptide-capped gold nanoparticles for enhanced siRNA delivery

Amir Nasrolahi Shirazi, Karissa L. Paquin, Niall G. Howlett, Dindyal Mandal, Keykavous Parang

Research output: Contribution to journalArticle

Abstract

Previously, we have reported the synthesis of a homochiral L-cyclic peptide [WR]5 and its use for delivery of anti-HIV drugs and biomolecules. A physical mixture of HAuCl4 and the peptide generated peptide-capped gold nanoparticles. Here, [WR]5 and [WR]5-AuNPs were tested for their efficiency to deliver a small interfering RNA molecule (siRNA) in human cervix adenocarcinoma (HeLa) cells. Flow cytometry investigation revealed that the intracellular uptake of a fluorescence-labeled non-targeting siRNA (200 nM) was enhanced in the presence of [WR]5 and [WR]5-AuNPs by 2- and 3.8-fold when compared with that of siRNA alone after 24 h incubation. Comparative toxicity results showed that [WR]5 and [WR]5-AuNPs were less toxic in cells compared to other available carrier systems, such as Lipofectamine.

Original languageEnglish (US)
Pages (from-to)13319-13331
Number of pages13
JournalMolecules
Volume19
Issue number9
DOIs
StatePublished - Aug 28 2014
Externally publishedYes

Fingerprint

Cyclic Peptides
Gold
Nanoparticles
Small Interfering RNA
peptides
delivery
gold
nanoparticles
Molecules
Anti-HIV Agents
molecules
Peptides
human immunodeficiency virus
cytometry
Flow cytometry
Poisons
wireless communication
Biomolecules
cells
HeLa Cells

Keywords

  • Cyclic peptides
  • Gold nanoparticles
  • SiRNA delivery systems (DDS)
  • Small interfering RNA (siRNA) delivery

ASJC Scopus subject areas

  • Organic Chemistry
  • Medicine(all)

Cite this

Shirazi, A. N., Paquin, K. L., Howlett, N. G., Mandal, D., & Parang, K. (2014). Cyclic peptide-capped gold nanoparticles for enhanced siRNA delivery. Molecules, 19(9), 13319-13331. https://doi.org/10.3390/molecules190913319

Cyclic peptide-capped gold nanoparticles for enhanced siRNA delivery. / Shirazi, Amir Nasrolahi; Paquin, Karissa L.; Howlett, Niall G.; Mandal, Dindyal; Parang, Keykavous.

In: Molecules, Vol. 19, No. 9, 28.08.2014, p. 13319-13331.

Research output: Contribution to journalArticle

Shirazi, AN, Paquin, KL, Howlett, NG, Mandal, D & Parang, K 2014, 'Cyclic peptide-capped gold nanoparticles for enhanced siRNA delivery', Molecules, vol. 19, no. 9, pp. 13319-13331. https://doi.org/10.3390/molecules190913319
Shirazi AN, Paquin KL, Howlett NG, Mandal D, Parang K. Cyclic peptide-capped gold nanoparticles for enhanced siRNA delivery. Molecules. 2014 Aug 28;19(9):13319-13331. https://doi.org/10.3390/molecules190913319
Shirazi, Amir Nasrolahi ; Paquin, Karissa L. ; Howlett, Niall G. ; Mandal, Dindyal ; Parang, Keykavous. / Cyclic peptide-capped gold nanoparticles for enhanced siRNA delivery. In: Molecules. 2014 ; Vol. 19, No. 9. pp. 13319-13331.
@article{cc11272b6daa43ba8e8a4292f39c17be,
title = "Cyclic peptide-capped gold nanoparticles for enhanced siRNA delivery",
abstract = "Previously, we have reported the synthesis of a homochiral L-cyclic peptide [WR]5 and its use for delivery of anti-HIV drugs and biomolecules. A physical mixture of HAuCl4 and the peptide generated peptide-capped gold nanoparticles. Here, [WR]5 and [WR]5-AuNPs were tested for their efficiency to deliver a small interfering RNA molecule (siRNA) in human cervix adenocarcinoma (HeLa) cells. Flow cytometry investigation revealed that the intracellular uptake of a fluorescence-labeled non-targeting siRNA (200 nM) was enhanced in the presence of [WR]5 and [WR]5-AuNPs by 2- and 3.8-fold when compared with that of siRNA alone after 24 h incubation. Comparative toxicity results showed that [WR]5 and [WR]5-AuNPs were less toxic in cells compared to other available carrier systems, such as Lipofectamine.",
keywords = "Cyclic peptides, Gold nanoparticles, SiRNA delivery systems (DDS), Small interfering RNA (siRNA) delivery",
author = "Shirazi, {Amir Nasrolahi} and Paquin, {Karissa L.} and Howlett, {Niall G.} and Dindyal Mandal and Keykavous Parang",
year = "2014",
month = "8",
day = "28",
doi = "10.3390/molecules190913319",
language = "English (US)",
volume = "19",
pages = "13319--13331",
journal = "Molecules",
issn = "1420-3049",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "9",

}

TY - JOUR

T1 - Cyclic peptide-capped gold nanoparticles for enhanced siRNA delivery

AU - Shirazi, Amir Nasrolahi

AU - Paquin, Karissa L.

AU - Howlett, Niall G.

AU - Mandal, Dindyal

AU - Parang, Keykavous

PY - 2014/8/28

Y1 - 2014/8/28

N2 - Previously, we have reported the synthesis of a homochiral L-cyclic peptide [WR]5 and its use for delivery of anti-HIV drugs and biomolecules. A physical mixture of HAuCl4 and the peptide generated peptide-capped gold nanoparticles. Here, [WR]5 and [WR]5-AuNPs were tested for their efficiency to deliver a small interfering RNA molecule (siRNA) in human cervix adenocarcinoma (HeLa) cells. Flow cytometry investigation revealed that the intracellular uptake of a fluorescence-labeled non-targeting siRNA (200 nM) was enhanced in the presence of [WR]5 and [WR]5-AuNPs by 2- and 3.8-fold when compared with that of siRNA alone after 24 h incubation. Comparative toxicity results showed that [WR]5 and [WR]5-AuNPs were less toxic in cells compared to other available carrier systems, such as Lipofectamine.

AB - Previously, we have reported the synthesis of a homochiral L-cyclic peptide [WR]5 and its use for delivery of anti-HIV drugs and biomolecules. A physical mixture of HAuCl4 and the peptide generated peptide-capped gold nanoparticles. Here, [WR]5 and [WR]5-AuNPs were tested for their efficiency to deliver a small interfering RNA molecule (siRNA) in human cervix adenocarcinoma (HeLa) cells. Flow cytometry investigation revealed that the intracellular uptake of a fluorescence-labeled non-targeting siRNA (200 nM) was enhanced in the presence of [WR]5 and [WR]5-AuNPs by 2- and 3.8-fold when compared with that of siRNA alone after 24 h incubation. Comparative toxicity results showed that [WR]5 and [WR]5-AuNPs were less toxic in cells compared to other available carrier systems, such as Lipofectamine.

KW - Cyclic peptides

KW - Gold nanoparticles

KW - SiRNA delivery systems (DDS)

KW - Small interfering RNA (siRNA) delivery

UR - http://www.scopus.com/inward/record.url?scp=84908146283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908146283&partnerID=8YFLogxK

U2 - 10.3390/molecules190913319

DO - 10.3390/molecules190913319

M3 - Article

VL - 19

SP - 13319

EP - 13331

JO - Molecules

JF - Molecules

SN - 1420-3049

IS - 9

ER -